| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
EWTX
Edgewise Therapeutics
|
Jun 17, 2026 | BUY |
Strong Buy
+27.2% avg upside
14 analysts
|
$52.00
49.27% Upside
|
· |
|
DNTH
Dianthus Therapeutics
|
Jun 15, 2026 | BUY |
Strong Buy
+9.8% avg upside
29 analysts
|
$105.00
28.18% Upside
|
-4.4% |
|
CLYM
Climb Bio
|
Jun 12, 2026 | BUY |
Strong Buy
+59.3% avg upside
18 analysts
|
$17.00
49.83% Upside
|
· |
|
TVTX
Travere Therapeutics
|
Jun 03, 2026 | BUY |
Strong Buy
-14.7% avg upside
22 analysts
|
$55.00
1.60% Upside
|
+15.1% |
|
PRAX
Praxis Precision Medicines
|
Jun 02, 2026 | SELL |
Strong Buy
+96.4% avg upside
24 analysts
|
$162.00
40.06% Downside
|
-3.2% |
|
JBIO
Jade Biosciences
|
Jun 02, 2026 | BUY |
Strong Buy
+233.0% avg upside
16 analysts
|
$45.00
166.77% Upside
|
-12.5% |
|
GOSS
Gossamer Bio
|
May 19, 2026 | HOLD |
Buy
+4259.1% avg upside
17 analysts
|
$1.00
458.74% Upside
|
· |
|
SION
Sionna Therapeutics, Inc.
|
May 18, 2026 | BUY |
Strong Buy
+46.5% avg upside
11 analysts
|
$53.00
44.27% Upside
|
-11.4% |
|
LRMR
Larimar Therapeutics
|
May 18, 2026 | BUY |
Strong Buy
+421.7% avg upside
21 analysts
|
$12.00
238.96% Upside
|
+4.9% |
|
SLDB
Solid Biosciences
|
May 18, 2026 | BUY |
Strong Buy
+112.8% avg upside
23 analysts
|
$16.00
118.89% Upside
|
· |
|
BIIB
Biogen
|
May 18, 2026 | HOLD |
Strong Buy
+24.4% avg upside
51 analysts
|
$196.00
1.27% Downside
|
+3.5% |
|
ANRO
Alto Neuroscience, Inc.
|
May 14, 2026 | HOLD |
Strong Buy
+37.7% avg upside
13 analysts
|
$24.00
10.06% Upside
|
-10.3% |
|
PEPG
PepGen Inc.
|
May 13, 2026 | BUY |
Strong Buy
+506.8% avg upside
8 analysts
|
$4.00
135.37% Upside
|
-12.9% |
|
OVID
Ovid Therapeutics
|
May 13, 2026 | BUY |
Strong Buy
+98.5% avg upside
17 analysts
|
$7.00
189.20% Upside
|
-6.1% |
|
PHVS
Pharvaris
|
May 13, 2026 | BUY |
Strong Buy
+36.1% avg upside
14 analysts
|
$42.00
25.63% Upside
|
+1.4% |
|
MAZE
Maze Therapeutics, Inc.
|
May 13, 2026 | BUY |
Strong Buy
+152.2% avg upside
12 analysts
|
$48.00
93.34% Upside
|
-7.9% |
|
RGTI
Rigetti Computing
|
May 12, 2026 | BUY |
Strong Buy
+50.1% avg upside
13 analysts
|
$40.00
97.54% Upside
|
-16.3% |
|
RARE
Ultragenyx Pharmaceutical
|
May 08, 2026 | HOLD |
Strong Buy
+144.1% avg upside
36 analysts
|
$26.00
3.32% Downside
|
-11.5% |
|
DNLI
Denali Therapeutics
|
May 08, 2026 | BUY |
Strong Buy
+58.8% avg upside
24 analysts
|
$23.00
2.15% Downside
|
+11.8% |
|
STOK
Stoke Therapeutics
|
May 08, 2026 | BUY |
Strong Buy
+28.2% avg upside
18 analysts
|
$38.00
25.57% Upside
|
-8.8% |
|
XENE
Xenon
|
May 08, 2026 | BUY |
Strong Buy
+18.6% avg upside
28 analysts
|
$63.00
18.37% Upside
|
-7.2% |
|
BCRX
BioCryst
|
May 07, 2026 | BUY |
Strong Buy
+102.2% avg upside
24 analysts
|
$21.00
134.64% Upside
|
-5.3% |
|
VRDN
Viridian Therapeutics
|
May 05, 2026 | BUY |
Strong Buy
+102.9% avg upside
32 analysts
|
$32.00
91.42% Upside
|
-14.1% |
|
NBIX
Neurocrine
|
Apr 07, 2026 | BUY |
Strong Buy
+8.0% avg upside
37 analysts
|
$166.00
4.44% Upside
|
+22.1% |
|
VERA
Vera Therapeutics
|
Jun 09, 2025 | HOLD |
Strong Buy
+90.9% avg upside
19 analysts
|
$23.00
34.22% Downside
|
+45.5% |
|
ARDX
Ardelyx
|
Nov 01, 2024 | BUY |
Strong Buy
+132.3% avg upside
21 analysts
|
$11.00
88.44% Upside
|
-0.5% |
|
VYGR
Voyager Therapeutics
|
Aug 07, 2024 | HOLD |
Strong Buy
+291.9% avg upside
23 analysts
|
$7.00
93.29% Upside
|
-54.3% |
|
RLYB
Rallybio
|
Apr 11, 2024 | BUY |
Buy
+15.3% avg upside
8 analysts
|
$11.00
30.87% Downside
|
-91.6% |
|
DSGN
Design Therapeutics
|
Mar 20, 2024 | HOLD |
Strong Buy
+47.9% avg upside
9 analysts
|
$5.00
58.06% Downside
|
+60.0% |
|
TSHA
Taysha Gene Therapies
|
Aug 12, 2022 | BUY |
Strong Buy
+108.8% avg upside
21 analysts
|
$5.00
19.23% Downside
|
-82.0% |
|
PASG
Passage Bio
|
Feb 11, 2022 | BUY |
Buy
+229.4% avg upside
14 analysts
|
$23.00
331.53% Upside
|
-67.6% |
|
TPST
Tempest Therapeutics
|
Aug 11, 2020 | HOLD |
Buy
+1646.8% avg upside
18 analysts
|
$45.00
3500.10% Upside
|
-51.5% |
|
VRTX
Vertex Pharmaceuticals
|
Jan 02, 2019 | HOLD |
Strong Buy
-3.9% avg upside
61 analysts
|
— | +33.8% |
|
BMRN
BioMarin Pharmaceutical
|
Jan 02, 2019 | HOLD |
Strong Buy
+71.7% avg upside
52 analysts
|
— | -1.1% |
|
IMUX
Immunic
|
Sep 12, 2018 | HOLD |
Strong Buy
+166.9% avg upside
21 analysts
|
— | -23.7% |
|
MTVA
MetaVia
|
Aug 13, 2018 | HOLD |
Strong Buy
+1656.7% avg upside
13 analysts
|
— | -61.5% |
|
REGN
Regeneron
|
Aug 08, 2018 | HOLD |
Strong Buy
+27.5% avg upside
57 analysts
|
— | -17.2% |
|
CRBP
Corbus Pharmaceuticals
|
Jan 18, 2018 | BUY |
Strong Buy
+346.7% avg upside
20 analysts
|
$24.00
198.17% Upside
|
-5.3% |
|
VIVS
VivoSim Labs
|
Jan 04, 2018 | HOLD |
Buy
+154.5% avg upside
5 analysts
|
— | -27.3% |
|
SGPYY
Sage Group
|
Dec 07, 2017 | BUY |
Buy
+82.2% avg upside
4 analysts
|
— | -25.7% |
|
TVRD
Tvardi Therapeutics
|
Jun 30, 2017 | BUY |
Buy
+601.3% avg upside
23 analysts
|
$30.00
1062.88% Upside
|
+24.4% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.